These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 31622991)

  • 1. Intermediate Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
    Eck RJ; Bult W; Wetterslev J; Gans ROB; Meijer K; Keus F; van der Horst ICC
    Semin Thromb Hemost; 2019 Nov; 45(8):810-824. PubMed ID: 31622991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Dose Low-Molecular-Weight Heparin for Thrombosis Prophylaxis: Systematic Review with Meta-Analysis and Trial Sequential Analysis.
    Eck RJ; Bult W; Wetterslev J; Gans ROB; Meijer K; van der Horst ICC; Keus F
    J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis.
    Eck RJ; Elling T; Sutton AJ; Wetterslev J; Gluud C; van der Horst ICC; Gans ROB; Meijer K; Keus F
    BMJ; 2022 Jul; 378():e070022. PubMed ID: 35788047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboprophylaxis With Apixaban in Patients Undergoing Major Orthopedic Surgery: Meta-Analysis and Trial-Sequential Analysis.
    Caldeira D; Rodrigues FB; Pinto FJ; Ferreira JJ; Costa J
    Clin Med Insights Blood Disord; 2017; 10():1179545X17704660. PubMed ID: 28579855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence based evaluation of immuno-coagulatory interventions in critical care.
    Afshari A
    Dan Med Bull; 2011 Sep; 58(9):B4316. PubMed ID: 21893014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis.
    Ben-Aharon I; Stemmer SM; Leibovici L; Shpilberg O; Sulkes A; Gafter-Gvili A
    Acta Oncol; 2014 Sep; 53(9):1230-7. PubMed ID: 25162954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
    Cheuk DK; Chiang AK; Ha SY; Chan GC
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009311. PubMed ID: 26017019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Labedi N; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2011 Nov; (11):CD009447. PubMed ID: 22071865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trials.
    Chapelle C; Rosencher N; Jacques Zufferey P; Mismetti P; Cucherat M; Laporte S;
    Arthroscopy; 2014 Aug; 30(8):987-96. PubMed ID: 24813323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
    Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
    Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.